Mucopolysaccharidosis Type I – Pipeline Insight, 2025: Exploring Emerging Therapies and Future Treatment Potential
Mucopolysaccharidosis Type I is a rare genetic lysosomal storage disease caused by the lack of the alpha-L-iduronidase enzyme. This enzyme deficiency results in the buildup of glycosaminoglycans (GAGs) in tissues and organs, leading to a range of symptoms that vary in intensity—from mild to severe. The condition is categorized into three forms: Hurler syndrome, Hurler-Scheie syndrome, and...
0 Комментарии 0 Поделились 661 Просмотры 0 предпросмотр
Talkfever - A Global Social Network https://willing-aqua-chinchilla.88-222-213-151.cpanel.site/